Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CAPN1

CAPN1

Basics

Aliases:
This biomarker is also known as:
  • Calcium-activated neutral proteinase 1,
  • muCANP,
  • CANP1,
  • Micromolar-calpain,
  • CANP 1,
  • CANP,
  • calpain 1, (mu/I) large subunit,
  • cell proliferation-inducing gene 30 protein,
  • Calpain mu-type,
  • cell proliferation-inducing protein 30,
  • calpain-1 large subunit,
  • Calpain-1 large subunit,
  • calpain-1 catalytic subunit,
  • muCL,
  • CANPL1,
  • calpain mu-type,
  • calpain, large polypeptide L1,
  • Cell proliferation-inducing gene 30 protein,
  • micromolar-calpain,
  • calcium-activated neutral proteinase 1,

View in BioMuta

Description…

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: CAPN1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.